THE INTEGRATED STRATEGIC PLAN STAR AWARD
As a leading biomedical institution, Stanford Medicine has a duty to all members of the community to think strategically as we advance toward the future. We have created and are delivering an Integrated Strategic Plan (ISP) for the future of Stanford Medicine that is critical to our leadership and vision in Precision Health. Our ISP brings together the three entities that comprise Stanford Medicine: Stanford School of Medicine, Stanford Health Care, and Stanford Children’s Health.
This honor recognizes individuals and teams from the Stanford Medicine community who, through their extraordinary efforts, embody the strategic priorities of our Integrated Strategic Plan (ISP): Value Focused, Digitally Driven, and Uniquely Stanford. By recognizing these important contributions, Stanford Medicine leadership hopes to further promote the ISP and accelerate its momentum.
The nomination process for the 2022 ISP Star Awards is closed.
2022 ISP STAR AWARD WINNERS
Commission on Justice & Equity Charged with the critical mission of strengthening Stanford Medicine’s diversity, equity, and inclusion (DEI) practices, better understanding our organizational culture, and addressing health equity, the Commission on Justice and Equity delivered emphatically. The Commission – with its membership comprising representatives from across our community and external DEI experts – engaged Stanford Medicine students, faculty, staff, and clinicians to identify opportunities for fostering greater inclusion and belonging on campus and becoming a national leader in addressing health disparities. Stanford Medicine leadership has actively implemented the Commission report’s insightful recommendations, including appointing an enterprise-wide Chief Diversity and Inclusion Officer.
RECOVER Team RECOVER combines Stanford Medicine’s unique strengths in translational and cross-disciplinary science while realizing our mission of using new knowledge to benefit humanity. This collaboration between multiple departments and groups stands as a national model in the study of Long COVID. Of the 15 sites in the country focused on studying this disease, RECOVER has one of the largest and fastest-growing number of human participants, and its initial contract resulted in four additional basic science awards. The rapid success has resulted in the study expanding to Stanford Health Care Tri-Valley, which will only further efforts to more precisely predict which patients will develop Long COVID in the future.
Patient Experience Measurement Modernization After three decades of using insufficient third-party vendors, the Office of Patient Experience pioneered a method for quickly and reliably measuring how patients perceive their care. This effort replaced outdated, resource-intensive patient experience measurement tools with a model that provided real-time data within hours of patient encounters, doubled the rate of patient satisfaction survey responses in six months, decreased IT workload through automation, and created dashboards for reporting data across the organization. Overall, the modernization of patient experience measurement enables Stanford Health Care to create a more patient-centric care environment.
National Clinical Trials Network (NCTN) Core Team Working across seven specialties, our National Clinical Trials Network Core Team developed a multifaceted strategy to break down siloes and establish synergies with specialty clinical research groups. These unique initiatives have simultaneously improved patient relationships, increased enrollment in clinical trials, and created smoother transitions for patients transitioning into long-term follow-up care – creating greater trust with patients and providing them access to novel treatments. Notably, the team’s innovative workflows have strengthened communications among staff and resulted in smoother transitions for patients, their families, and health care providers.
Transplantation Tolerance through Hematopoietic Chimerism Drs. Alice Bertaina and David Lewis developed a groundbreaking method for performing pediatric kidney transplants without immune-suppressing drugs. They discovered that transplanting the donor’s immune system to the patient before surgery removes the possibility that the recipient will experience immune rejection, eliminates the side effects of a lifetime of immune-suppressing medications, and enables transplantation between a donor and recipient whose immune systems are genetically half-matched, such as a child and parent. This uniquely Stanford approach to patient care will have profound benefits at Stanford Medicine Children’s Health and beyond as the protocol received FDA approval in May 2022.
2021 ISP STAR AWARD WINNERS
Research Participation Application The team created the Participant Engagement Platform (PEP), to improve our research infrastructure and processes at Stanford Medicine. Their efforts have enabled outreach to thousands more study participants, which has transformed how we engage participants and created tremendous value across our many research programs. This initiative was funded by the Stanford CTSA Award Number UL1TR003142 from the National Center for Advancing Translational Science (NCATS), a component of the National Institutes of Health.
SHC, SCH, SHC-VC Infection Prevention & Control The Infection Prevention and Control (IPC) Departments for Stanford Health Care, Stanford Children’s Health, and Stanford Health Care – Valley Care initiated the “Joint IPC Huddle” at the start of the COVID-19 pandemic, which streamlined pandemic response work between the SHC, SCH and SHC–VC IPC programs. Their leadership created policies and program alignment and demonstrated unprecedented collaboration that will will last long after the pandemic is contained.
Stanford Children’s Health Clinical Research Support Office The Stanford Children’s Health Clinical Research Support Office established an inaugural SCH Clinical Research IS Governance committee with membership from Hospital Privacy, SCH IS, TDS to adjudicate research IS initiatives that necessitated alignment across SCH, SHC, and SoM. The work of the Clinical Research Support Office has continued to advance the clinical and translational research infrastructure and has created sustainable processes and models for enabling research recruitment and providing Epic access for researchers.
Stanford Health Care Enterprise Transfer Center The Stanford Health Care Enterprise Transfer Center team redesigned the enterprise transfer center, leading to a significant decrease in denials of ICU patient transfers due to capacity constraints by more than 10% since the opening of 500P. They met the FY2021 operational plan goals by increasing target population transfers by 5% from FY2020, and identified the workflow for outside referring physicians and internal on-call physicians.
The Stanford Our Voice (OV) Research Initiative: Citizen Science for Health Equity Over the past decade, Our Voice (OV) has engaged diverse groups of citizen scientists across the Bay Area, US, and in underserved communities around the world to successfully catalyze change in local policies and build social environments to support healthy living. Their work has empowered individuals with the right tools to make their local communities healthier.
Stanford Medicine Vaccine Governance Committee The Stanford Medicine Vaccine Governance Committee provided oversight on the longer-term vaccine strategy to ensure equitable distribution among Stanford Medicine, Stanford University, patients, and the broader community. The leadership demonstrated by this governance group created remarkably high level of vaccine confidence in the Stanford Medicine community, enabling Stanford Medicine to administer more than 500,000 COVID-19 vaccines. The committee’s work is a testament to Stanford Medicine’s personal commitment to protecting the health of our patients, community, and colleagues.
2020 ISP STAR AWARD WINNERS
Clinical Effectiveness Target Based Care Core Team This team created a method to promote a shared mental model of hospital goals by presenting “achievable benchmarks” from prior like-encounters at the point of care for all stakeholders, including the family. By developing tools that facilitate continuous learning and improvement while preserving safety and patient experience, the Clinical Effectiveness Target Based Care Core team has demonstrated innovative thinking that will streamline and enhance care
Clinical Virology Team By designing and validating an in-house diagnostic test for the novel coronavirus, the Clinical Virology team helped limit the spread of the virus. This effort borne of innovative thinking and strategic collaborations exemplifies how our community’s work has an impact on health locally and globally.
Emergency Department Teams The Emergency Department’s response before and during the COVID-19 pandemic embodies Stanford Medicine’s commitment to high-tech, high-touch care. This model of care puts patients at the center of their care journey, improves outcomes, and creates better experiences for patients and their families.
Kidney Transplant Team The Kidney Transplant (KT) team, under Dr. Busque and Dr. Scandling's leadership, has worked collaboratively and diligently to achieve and deliver excellence in patient care. By continuously identifying opportunities to improve patient care, the Kidney Transplant team has established itself as one of the highest-performing teams in the United States based on several metrics.
MyHealth – Hospital View Team The MyHealth – Hospital View team created a view in which patients can view members of the care team, test results, medications/side effects, progress against goals including pain and mobility & information to prepare for discharge. This provides a personalized care experience that enables patients and their families to focus on health, healing, and recovery.
Network Access Optimization Team The Network Access Optimization team optimized how patients schedule primary care appointments at all Faculty and UHA primary care clinics by creating a common work queue driven by patient preferences, increasing scheduling visibility across system, and enabling self-scheduling and positive user experience.
Stanford Cancer Center’s Tobacco Treatment Service Team The Tobacco Treatment Service team’s ability to bridge the School of Medicine’s expertise in tobacco cessation research with Stanford Health Care’s patient care environment has streamlined critical patient care. The team developed an “opt-out” approach to remove referral requirements, allowing providers to focus on immediate patient needs while ensuring access to evidence-based treatment. Cessation support options for patients include: same-day delivery of cessation medications through a partner pharmacy and counseling.
SURF (System Utilization Research for Stanford Medicine) Team SURF uses advanced technology derived from data science and machine learning to make a concrete difference in how Stanford cares for patients. Their use of data science and machine learning to reduce CLABSI infections, optimize patient flow, predict clinical events, and enhance patient care in myriad other ways exemplifies the profound impact Stanford Medicine has through cross-functional collaboration and innovative thinking.
UHA/SHC Dermatology Team Employing technology, innovation and teamwork, this team has created new and convenient access points to specialty services. By expanding dermatology service options to patients at several UHA locations while pivoting to telehealth, the UHA/SHC Dermatology team exemplifies how a digitally driven approach can streamline and expand access to high-quality care.
2019 ISP STAR AWARD WINNERS
Tim Keyes Through Tim’s development and teaching of the first-year LGBTQ pre-clinical curriculum, service as co-chair of the Minority Medical Alliance, and efforts to develop the LGBTQ+ Forum, Tim has proven to be an exceptional leader and advocate for the LGBTQ+ community. Tim’s efforts have made Stanford Medicine more diverse and more inclusive and will have a lasting and profound effect on or community.
Who can be nominated for the ISP Star Awards?
Any individuals/teams from the Stanford Medicine Community (SOM, SHC, SCH, TriValley, SMP, PCHA, UMP). Those who wish to submit a nomination should demonstrate how the work (a current initiative, new project, etc.) directly contributes to one or more of the ISP's three strategic priorities: value focused, digitally driven, uniquely Stanford.
How often will the awards be given?
Awards are presented to winners annually in the Fall. Nominations for the 2022 ISP Star Award winners are closed.
How can nominations be submitted?
Faculty and staff can nominate individuals via a web form on our ISP website. A committee will review nominations and determine award recipients.
Can I nominate myself?
Absolutely! If you believe you are deserving of an award, please submit a nomination for yourself via our web form.
What will the award recipients receive?
Award recipients will receive a certificate and gift in recognition of their accomplishments.